Skip to main content
Premium Trial:

Request an Annual Quote

William Sullivan, Kevin Johnson, Giannni Garotta, Ennio Ongini, Randy Jones

Premium

William Sullivan has been ap-pointed vice president of diagnostics operations at Ciphergen’s new diagnostics division. Before joining Ciphergen, he was vice president of diagnostic manufacturing at Visible Genetics. Sullivan holds an AB degree from the College of the Holy Cross and attended graduate school at the University of Pennsylvania.


Kevin Johnson and Giannni Garotta have joined European venture capital firm Index Ventures as executives in residence, and Ennio Ongini as venture advisor. Johnson was most recently chief technology officer of Cambridge Antibody Technologies. Garotta used to be vice president for academic collaborations at Serono. Ongini is cur-rently head of discovery at Nicox.


Randy Jones has been named director of toxicology for the Arkansas discovery and development services division of Charles River Laboratories. Jones previously held a regulatory affairs management position at Primus. Prior to that, he spent 10 years as senior toxicologist at Bayer. He holds a PhD from the University of Georgia and a doctorate of veterinary medicine from Iowa State University.

 

 

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.